Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention1: HAPID�® Capsule: Aflapin 100 mg and un-denatured type II collagen 40 mg, Once daily, Orally, 90 days
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Wockhardt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Ambulatory adult patient, clinically or radiologically confirmed diagnosis of Knee Osteoarthritis newly prescribed with HAPID�® (Un-denatured Type II Collagen and Aflapin), willing to provide written informed consent and comply to the study as per protocol
Exclusion criteria
Exclusion criteria: 1. History or evidence of hypersensitivity to any component of study medication 2. History of viscosupplementation within 9 months prior to date of screening 3. History of allergy to eggs or chicken 4. Pregnant or lactating women 5. Any other reason which in opinion of investigator preludes participation in study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in Mean overall WOMAC score 2. Change in Mean VAS score 3. Change in Mean WOMAC subscalesTimepoint: Day 1, Day 5, Day 30, Day 60 and Day 90. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Adverse Events, during treatment with HAPIDÃ?®Timepoint: Day 1, Day 5, Day 30, Day 60 and Day 90. | — |
Countries
India
Contacts
Public ContactDr Khokan Debnath
Wockhardt Ltd.
Outcome results
None listed